{"name":"Shenzhen Salubris Pharmaceuticals Co., Ltd.","slug":"shenzhen-salubris-pharmaceuticals-co-ltd","ticker":"","exchange":"","domain":"shenzhensalubris.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"immunology","drugs":[{"name":"FORSTEO","genericName":"FORSTEO","slug":"forsteo","indication":"Osteoporosis in postmenopausal women","status":"marketed"},{"name":"SAL-0951","genericName":"SAL-0951","slug":"sal-0951","indication":"Other","status":"phase_3"},{"name":"Enarodustat 2mg","genericName":"Enarodustat 2mg","slug":"enarodustat-2mg","indication":"Other","status":"marketed"},{"name":"SAL067","genericName":"SAL067","slug":"sal067","indication":"Other","status":"phase_3"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Allisartan Isoproxil/Sustained-Release Indapamide","genericName":"Allisartan Isoproxil/Sustained-Release Indapamide","slug":"allisartan-isoproxil-sustained-release-indapamide","indication":"Hypertension","status":"phase_3"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"SAL-0951 tablets","genericName":"SAL-0951 tablets","slug":"sal-0951-tablets","indication":"Type 2 diabetes","status":"phase_3"}]},{"name":"Respiratory","slug":"respiratory","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"neuroscience","drugs":[{"name":"SAL056 (56.5μg)","genericName":"SAL056 (56.5μg)","slug":"sal056-56-5-g","indication":"Asthma (maintenance therapy)","status":"phase_3"}]}],"pipeline":[{"name":"Allisartan Isoproxil/Sustained-Release Indapamide","genericName":"Allisartan Isoproxil/Sustained-Release Indapamide","slug":"allisartan-isoproxil-sustained-release-indapamide","phase":"phase_3","mechanism":"This combination drug lowers blood pressure by blocking angiotensin II receptors (allisartan isoproxil) and inhibiting sodium reabsorption in the kidney (sustained-release indapamide).","indications":["Hypertension"],"catalyst":""},{"name":"FORSTEO","genericName":"FORSTEO","slug":"forsteo","phase":"marketed","mechanism":"Forsteo (teriparatide) is a recombinant human parathyroid hormone analog that stimulates bone formation by activating PTH1 receptors on osteoblasts.","indications":["Osteoporosis in postmenopausal women","Osteoporosis in men at high risk of fracture","Glucocorticoid-induced osteoporosis"],"catalyst":""},{"name":"SAL-0951","genericName":"SAL-0951","slug":"sal-0951","phase":"phase_3","mechanism":"SAL-0951 is a small molecule inhibitor targeting a specific molecular pathway involved in disease pathogenesis.","indications":[],"catalyst":""},{"name":"Enarodustat 2mg","genericName":"Enarodustat 2mg","slug":"enarodustat-2mg","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"SAL-0951 tablets","genericName":"SAL-0951 tablets","slug":"sal-0951-tablets","phase":"phase_3","mechanism":"SAL-0951 tablets are a small molecule drug that targets the SGLT2 receptor.","indications":["Type 2 diabetes","Chronic kidney disease"],"catalyst":""},{"name":"SAL056 (56.5μg)","genericName":"SAL056 (56.5μg)","slug":"sal056-56-5-g","phase":"phase_3","mechanism":"SAL056 is an inhaled corticosteroid that reduces airway inflammation by binding to glucocorticoid receptors in lung tissue.","indications":["Asthma (maintenance therapy)","Chronic obstructive pulmonary disease (COPD)"],"catalyst":""},{"name":"SAL067","genericName":"SAL067","slug":"sal067","phase":"phase_3","mechanism":"SAL067 is a small-molecule inhibitor targeting a specific kinase or receptor involved in disease pathogenesis.","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQSDJIQUtuTU1OZ2gxMXVLQnNwd2dWalU0YWVtQThSa3IzeWRES0x6SEtCYW1BQlo5cXRvY1ZKaXMxaExHWFhqX3N3SVlTV2F4Z1RiLWZtVjI5ejVwSmRWVktacHZIbVh4UVRHZFBpSkxTdmNVbGFPZ3puQjBjOUQyQnRQeHZBTW1XSXI4?oc=5","date":"2026-03-02","type":"pipeline","source":"Pharma Voice","summary":"Big Pharma’s next entrant could come from China - Pharma Voice","headline":"Big Pharma’s next entrant could come from China","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxOQk8xcmM1b0pkdXBGS1kzTmZ3MUI2a0dVZDRBc0JMSlR1aEVXT3NfZGFSZ25PdlBvNmhsWEdrZjJkOHdua1lnZU5oaDNHM1lZNVN3NzBSRUpfem9CQU9KcmZtVzFJd2lTTS1TSjNjV0Y5UkdZQy1KRmZQRENvT2Z2NTVUY2FQQ2Jra0hyZ2VkVXBvM3M?oc=5","date":"2025-01-14","type":"pipeline","source":"BioWorld News","summary":"CSPC wins China clearance of new DPP-4 inhibitor - BioWorld News","headline":"CSPC wins China clearance of new DPP-4 inhibitor","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-wFBVV95cUxQTW9Zc2Y4LTRLaE5CeEZxQWlrUmJLMVBuMEtfWjc2OUlSaUJHbjBJQVNVbTBWdUZWREpvTno2M3FYM0NGR2d1X0NpWVlOMDdHLVN5ejhibXdic3MxWmZZbFFYaERtZmdZSHFxdWw0VDhUMTNmcmJLZTAwaU9GNlFrcG1pRjVIZ2ZSZ1N6OFFEckd6RWlZTWtLRzEwV1pBSFU3dlk5cGFxNGtxYUZXWEM1YzBWdDVuNXJwRWc4clE4bVdOR3VpMkticFFobXkyLW9TMEtKWFhibjF3WWxtQ3hVTGwzbHZoNlVxbzZQZVJSSFlmRE1VcGNZa0JjOA?oc=5","date":"2021-09-27","type":"pipeline","source":"businesswire.com","summary":"D&D Pharmatech Announces Agreement with Salubris Pharmaceuticals for Licensing and Development of DD01 in China - businesswire.com","headline":"D&D Pharmatech Announces Agreement with Salubris Pharmaceuticals for Licensing and Development of DD01 in China","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxOaWtjTzZxWEZWeWRrWWdqbFZyUUVHQlBIREVjZk4wa05QTzVONlZzQk9lal9rWWROMGRzaTNTX29lUkJVbk9zZm82ZGdiWjk3WTMxRlVOTlFmOThkVWRCRXRqUEFyTmZrc3ZfQm80Z1JLcjRBY3lGdmYzc1VfUEtBVmw1dnR4YU9LV3RMTVdCQQ?oc=5","date":"2020-08-23","type":"pipeline","source":"marketscreener.com","summary":"Ambalal Sarabhai Enterprises Limited: Shareholders Board Members Managers and Company Profile | INE432A01017 - marketscreener.com","headline":"Ambalal Sarabhai Enterprises Limited: Shareholders Board Members Managers and Company Profile | INE432A01017","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxOcGhXWWhMdnVmMHR6TE9GNzgxWjFhbk5uaHVpUEhvQkNqVXhxTFV3c2hxYTNSX3JUMXlQVGs2MUhQdmhORllEWmRiY1hXMWFvMlRma1h1R0Ftam51OWpaQVJnUVZZQWkzQ1FaVmFPOFZtOVo1ajNUblVnc3J0eFNJa1hQZTlma3hCcUVhejdR?oc=5","date":"2020-08-22","type":"pipeline","source":"marketscreener.com","summary":"STAR Pharmaceutical Limited: Shareholders Board Members Managers and Company Profile | SG1BB3000009 - marketscreener.com","headline":"STAR Pharmaceutical Limited: Shareholders Board Members Managers and Company Profile | SG1BB3000009","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxOVmhyLVNGaHd0YTJKZ29MakRzN2Q5SmRhN2NHNXZ2clpOWGllRDlaR0JkX1hwbnAwSEdJdGViX1lmVDd2aGVqZEdRTzBLZnZvS1BuUEZqaXVDajVIakpabWE3bXdHMHBvQ2dyWlZTWU9RWDE2SzZGRDdVU0dNNU5sOF9fMVE2SldvajFfQlZNQQ?oc=5","date":"2020-08-19","type":"pipeline","source":"marketscreener.com","summary":"Kwang Dong Pharmaceutical Co., Ltd.: Shareholders Board Members Managers and Company Profile | KR7009290008 - marketscreener.com","headline":"Kwang Dong Pharmaceutical Co., Ltd.: Shareholders Board Members Managers and Company Profile | KR7009290008","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxNaXRwN0ZGZTdRZWlkRjZ6MWRiSTlSNENhbF9ZNlJFWlplelR6Qzh5dGplbVhsYUJHd21TWXBSZFRZMVJHRld3QzRPc0dabmpyWEkxV2p4UVlmOF91Y21LbjFESllmMTlmTnJrSGVsVGdJWEZ1U2t1ZjExd2ktcXdCNDV3eVlJY2FqVkwzRVl3?oc=5","date":"2020-08-18","type":"pipeline","source":"marketscreener.com","summary":"Strides Pharma Science Limited: Shareholders Board Members Managers and Company Profile | INE939A01011 - marketscreener.com","headline":"Strides Pharma Science Limited: Shareholders Board Members Managers and Company Profile | INE939A01011","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxNd3F0Q3hDLWxqZ1dfN2JDdzRGZDlpc0lkVU52TnpPV0VFWGc2WnROZ1g1N1ByR0pEU0g2c0w4QVY0cEM0OU13YXVvQ2V1RlRBanlVU29jdUctbEpUNkY3Q2tnZ1hhbjVObFJ2clJjbDV5VDctc0dFbVozQ05LX2w4UFhJV3VtRlRkdzNGZXA1cW4?oc=5","date":"2020-08-18","type":"pipeline","source":"marketscreener.com","summary":"SUN PHARMACEUTICAL INDUSTRIES LTD. - marketscreener.com","headline":"SUN PHARMACEUTICAL INDUSTRIES LTD.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTFBtclRJQS02V0ZFM05ocjc1Rnd4cHNvUm5TSERMcWJjZjViU1pQUUNTMHBRYmtQVkVLNDdMeHlDWm95MTZkZWEwcWtIY191Sk84SWtLQU5DaS1Wdl83TUhFXzJDRURJcEhzZ2ZCR0dYNV9vUjEtT19mRA?oc=5","date":"2020-08-18","type":"pipeline","source":"marketscreener.com","summary":"STADA Arzneimittel Stock (SAZ) - Quote Xetra - marketscreener.com","headline":"STADA Arzneimittel Stock (SAZ) - Quote Xetra","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxPSWUtTzZ5UWlRcTQySGhjZ2xkZ2UzRElQNncwOHJJTDluQzRnN0FCaEFGYjR5aGwxWk80bEQ2S2lYZXdsQV9Ga2ZDcFhRcHNMd0NuRmZLSEtJMUtaWmJIbmtaQWo3dXJiYjJkOW1QUmpzR2JacWRpN0RDb0pyTnhzMmdReW5oRW5GRXhKNDJwUFk?oc=5","date":"2020-08-10","type":"deal","source":"pe-insights.com","summary":"Carlyle Buys Stake in Chinese Health-Care Firm for $260 Million - pe-insights.com","headline":"Carlyle Buys Stake in Chinese Health-Care Firm for $260 Million - pe","sentiment":"neutral"}],"patents":[],"drugCount":7,"phaseCounts":{"phase_3":5,"marketed":2},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}